FABP7-mediated lipid-laden macrophages drive the formation of pre-metastatic niche and liver metastasis

Shaowan Xu, Xin Peng, Zhenfang Wang, Chenchen Le, Xiangkun Wu, Zhicheng Zeng, Sisi Zeng, Ceng Zhang, Mingxing Qiu, Xin Zou, Hongxia Zhang, Fangfang Wang, Wei Kang, Yanqing Ding, Li LiangInternational Journal of Biological Sciences 2025 · DOI

TL;DR

This study reveals a novel mechanism where FABP7 in liver macrophages drives the formation of a pre-metastatic niche (PMN) by promoting lipid accumulation. These lipid-laden macrophages then reprogram CD8+ T cells and tumor cells via exosomal lipid transfer, ultimately promoting liver metastasis. Targeting FABP7 shows promise as a therapeutic strategy.

What Problem Does This Paper Address?

Metastasis, the spread of cancer to distant organs, is the primary cause of cancer-related deaths. The liver is a common site for metastasis, especially from gastrointestinal cancers. Before cancer cells can successfully colonize a secondary organ, the primary tumor establishes a "pre-metastatic niche" (PMN) – a supportive microenvironment. While macrophages are known to play a crucial role in forming this niche, the specific metabolic reprogramming of these macrophages, particularly concerning lipid metabolism, and its contribution to liver metastasis, remained largely unclear. This paper aims to elucidate the precise mechanisms by which macrophages in the liver PMN contribute to metastasis, focusing on the role of FABP7 and lipid metabolism.

Methods

The researchers employed a multi-faceted approach:

  • In vivo mouse models: They used intrasplenic injection of MC38 (colorectal cancer) and PAN02 (pancreatic ductal adenocarcinoma) cells in mice to establish liver metastasis models. They also utilized FABP7 knockout (KO) mice and treated wild-type mice with a FABP7 inhibitor (SBFI-26).
  • Cell culture and manipulation: They used various cell lines (MC38, PAN02, RAW264.7, 293T) and primary cells (bone marrow-derived macrophages - BMDMs). Techniques included overexpression (OE) and knockdown of genes, hypoxia induction (CoCl2, 1% O2), and treatment with inhibitors (SBFI-26, A922500, GW4869, etomoxir).
  • Molecular and cellular analyses:
    • Immunohistochemistry (IHC) and Immunofluorescence (IF): To visualize protein expression (FABP7, HIF-1α, CD68, CD163, ADRP) and cellular localization in tissue samples.
  • Western Blotting: To quantify protein levels.
  • Quantitative PCR (qPCR): To measure mRNA expression of various genes.
  • Flow Cytometry: To analyze cell populations, macrophage polarization (M1/M2 markers), lipid droplet (LD) accumulation (BODIPY staining), and T cell function (cytokine production, exhaustion markers).
  • Seahorse XF Analyzer: To measure cellular energy metabolism, including oxygen consumption rate (OCR) and extracellular acidification rate (ECAR), assessing mitochondrial respiration and glycolysis.
  • Lipidomic analysis: Using mass spectrometry (MS) to identify and quantify metabolites.
  • Exosome isolation and characterization: Using ultracentrifugation and nanoparticle tracking analysis (NTA) to isolate and quantify exosomes.
  • ChIP-qPCR and Luciferase Reporter Assays: To investigate the transcriptional regulation of FABP7 by HIF-1α.
  • Bioinformatics analysis: Public gene expression datasets (GEO) were analyzed to identify differentially expressed genes. Kaplan-Meier plotter was used for survival analysis.

Datasets

  • Public Gene Expression Datasets:
    • GSE156429: Compared liver Kupffer cells between control mice and colorectal cancer (CRC) metastasis models.
  • GSE109480: Evaluated pre-metastatic liver tissues in Kras/p53-driven pancreatic cancer models.
  • GEO dataset GSE131418: Analyzed FABP7 and HIF-1α expression in CRC liver metastasis patients.
  • Human Samples: Paraffin-embedded blocks of human CRC and PDAC tissues from Nanfang Hospital were used for IHC and IF analysis.
  • RNA-seq Data: Generated from liver macrophages of WT and FABP7-/- mice bearing MC38 tumors, deposited in GEO under accession number GSE244156.

Key Insights and Ideas

  • FABP7 as a key player in liver PMN formation: The study strongly implicates FABP7 in the early stages of liver metastasis by promoting the formation of a lipid-rich environment within macrophages.
  • Hypoxia-driven FABP7 upregulation: The research uncovers a critical link between tumor hypoxia, HIF-1α activation, and subsequent FABP7 expression in liver macrophages, highlighting a specific mechanism for FABP7 induction in the PMN.
  • Lipid droplets as a central hub: FABP7's role in driving lipid droplet accumulation in macrophages is a core finding, suggesting that these droplets are not just storage but active contributors to metastasis.
  • Macrophage-to-T cell/tumor cell communication via exosomes: The discovery that lipid-laden macrophages transfer lipids to CD8+ T cells and tumor cells through exosomes is a significant insight into intercellular communication in metastasis.
  • Metabolic reprogramming as a driver of dysfunction: The study demonstrates how this lipid transfer impairs CD8+ T cell function and fuels tumor cell proliferation, underscoring the importance of metabolic crosstalk.
  • FABP7 as a prognostic and therapeutic target: The correlation between FABP7 expression and poor patient outcomes, along with the efficacy of FABP7 inhibition in preclinical models, positions FABP7 as a promising biomarker and therapeutic target.

Key Results

  • FABP7 expression is significantly upregulated in liver macrophages during the pre-metastatic niche (PMN) and metastatic niche (MMN) stages of liver metastasis.
  • Hypoxia, via HIF-1α, transcriptionally activates FABP7 in liver macrophages, leading to increased lipid droplet (LD) accumulation.
  • FABP7 promotes M2 polarization of macrophages, which is dependent on fatty acid oxidation (FAO).
  • FABP7-induced LD accumulation in macrophages is mediated by DGAT1.
  • Lipid-laden macrophages transfer lipids to CD8+ T cells and tumor cells via exosomes.
  • This lipid transfer impairs CD8+ T cell function (reduced oxidative phosphorylation, glycolysis, increased exhaustion markers) and promotes tumor cell proliferation.
  • Genetic knockout or pharmacological inhibition of FABP7 significantly reduced liver metastasis in mouse models.
  • Higher FABP7 expression in human CRC patients correlates with worse overall survival (OS) and relapse-free survival (RFS).

Limitations and Future Work

  • Organ specificity: While the study focuses on liver metastasis, the authors note that FABP7 expression was minimal in macrophages from lung, bone, or spleen during the PMN phase. Future work could explore FABP7's role in other metastatic sites.
  • Complex TME interactions: The study highlights the interaction between macrophages, CD8+ T cells, and tumor cells. Further research could delve deeper into the intricate signaling networks and the precise molecular mechanisms of exosomal lipid transfer and its downstream effects.
  • Clinical translation: While FABP7 shows promise as a therapeutic target, further studies are needed to optimize drug delivery, assess long-term efficacy, and evaluate potential side effects in clinical trials. The authors suggest targeting FABP7 may offer prognostic and therapeutic potential, implying a need for further clinical investigation.
  • Exosome cargo diversity: The study focuses on lipid transfer via exosomes. Future research could investigate other exosomal components that might contribute to the metastatic process.

Summary updated

Abstract

Abnormal metabolism processes play a crucial role in the establishment of the pre-metastatic niche (PMN) and the subsequent metastasis to distant organs. However, the precise mechanisms underlying the lipid metabolic reprogramming of macrophages within the liver PMN remain elusive. In this study, we observed an upregulation of fatty acid-binding protein 7 (FABP7) in liver macrophages, which resulted in the accumulation of lipid droplets (LDs) within the PMN of colorectal cancer and pancreatic ductal adenocarcinoma. This accumulation was found to be mediated by the HIF-1α-induced expression of FABP7, which in turn enhanced DGAT1 activity in these macrophages. Furthermore, FABP7-induced lipid-laden macrophages were observed to deliver lipids to CD8<sup>+</sup> T and tumor cells via exosomes. This process led to CD8<sup>+</sup> T cell dysfunction and increased tumor cell proliferation through metabolic reprogramming. Importantly, genetic knockout or pharmacological inhibition of FABP7 reduced liver metastasis. Our findings reveal a novel mechanism involving FABP7-mediated LD in macrophages that contributes to liver PMN formation and metastasis. This suggests that targeting FABP7 may offer prognostic and therapeutic potential in addressing liver metastasis.
BibTeX
@article{xu2025fabp,
  author = {Shaowan Xu and Xin Peng and Zhenfang Wang and Chenchen Le and Xiangkun Wu and Zhicheng Zeng and Sisi Zeng and Ceng Zhang and Mingxing Qiu and Xin Zou and Hongxia Zhang and Fangfang Wang and Wei Kang and Yanqing Ding and Li Liang},
  title = {{FABP7-mediated lipid-laden macrophages drive the formation of pre-metastatic niche and liver metastasis}},
  journal = {International Journal of Biological Sciences},
  year = {2025},
  doi = {10.7150/ijbs.110750},
}
Figure